trending Market Intelligence /marketintelligence/en/news-insights/trending/zmo1h3ytgrgoebmkeigzjg2 content esgSubNav
In This List

Rigel Pharmaceuticals appoints CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Rigel Pharmaceuticals appoints CFO

Rigel Pharmaceuticals Inc. appointed Dean Schorno as executive vice president and CFO.

Schorno previously served as CFO and head of operations at 23andMe Inc., which operates as a personal genetics company.